Summary
Latest filing:
Joseph J. Ferra Jr. is CHIEF EXECUTIVE OFFICER of Elevation Oncology, Inc. (ELEV). 1 SEC Form 4 filing on record, dated 18 December 2024.
Recent Transactions
2Every recent SEC Form 4 transaction Joseph J. Ferra Jr. has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Joseph J. Ferra Jr. go back to 2024: 1 primary Form 4 filing, an average of 0.3 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other Insiders Active in the Same Sector
No other insider has filed at Joseph J. Ferra Jr.'s companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Mayukh Sukhatme - $109.13M of ROIV open-market activity in the last 12 months
- Herriot Tabuteau - $103.22M of AXSM open-market activity in the last 12 months
- Bruce Booth - $100.59M of KYMR open-market activity in the last 12 months
- ADAR1 Capital Management, LLC - $95.66M of KROS open-market activity in the last 12 months
- Paul A. Mahon - $94.95M of UTHR open-market activity in the last 12 months
- Steven Leonard Chapman - $93.07M of NTRA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Joseph J. Ferra Jr.?
Joseph J. Ferra Jr. is a corporate insider, tracked as CHIEF EXECUTIVE OFFICER of Elevation Oncology, Inc. (ELEV). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Joseph J. Ferra Jr. last file a Form 4?
The only primary Form 4 on record is dated 18 December 2024.
Where can I see all of Joseph J. Ferra Jr.'s SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Joseph J. Ferra Jr. and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial